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Abstract  36 
Cytolytic proteins and peptide toxins are classical virulence factors of several bacterial 37 
pathogens which disrupt epithelial barrier function, damage cells and activate or modulate host 38 
immune responses1,2.  Here we identify the first cytolytic peptide toxin in a human pathogenic 39 
fungus.  This peptide (Ece1-III) is generated from a parent protein, Ece1p, and is produced by 40 
the invasive hyphal form of the opportunistic fungal pathogen Candida albicans.  Ece1-III 41 
directly damages epithelial membranes and, at sub-lytic concentrations, triggers a danger 42 
response pathway, activating epithelial immunity.  C. albicans strains lacking Ece1-III do not 43 
activate or damage epithelial cells and are avirulent in animal models of mucosal infection.  44 
This amphipathic peptide adopts an α-helical structure that causes cytolysis of multiple human 45 
epithelial cell types.  Membrane permeabilization is enhanced by a positively charged C-46 
terminus and triggers an inward current concomitant with calcium influx.  Given its cytolytic 47 
activity, we propose the name ‘Candidalysin’ for Ece1-III.  Candidalysin is the first described 48 
cytolytic peptide toxin of a human fungal pathogen and is a critical molecular determinant of 49 
epithelial damage and host recognition of the clinically important fungus, C. albicans. 50 
 51 
 52 
Results 53 
Normally a benign member of human microbiota, Candida albicans is responsible for millions 54 
of mucosal infections each year, often with severe morbidity3.  A defining feature of C. albicans 55 
pathogenesis is the transition from yeast to invasive filamentous hyphae.  Hyphae damage 56 
mucosal epithelia and induce activation of the the activating protein-1 (AP-1) transcription 57 
factor c-Fos (via p38-MAPK) and the MAPK phosphatase MKP1 (via ERK1/2-MAPK), which 58 
trigger pro-inflammatory cytokine responses4,5.  These signaling events constitute a ‘danger 59 
response’ against invasive hyphae, thus serving as a sensor of pathogenic C. albicans invasion 60 
6,7. 61 
Despite the well-known association between filamentation and virulence, the molecular 62 
mechanism underlying hypha-driven epithelial activation and mucosal damage has remained 63 
obscure.  To elucidate this mechanism, we screened a panel of C. albicans gene deletion 64 
mutants that targeted key processes, pathways and proteins known or predicted to be associated 65 
with the yeast-hyphal transition and pathogenicity (n = 62).  Only hypha-producing strains 66 
induced MKP1 phosphorylation (p-MKP1), c-Fos, cytokines (IL-1α, IL-6, G-CSF) and damage 67 
in oral epithelial cells (Extended Data Table 1).  However, one C.albicans mutant (ece1Δ/Δ)8 68 
formed normal hyphae but was incapable of inducing these epithelial danger responses.  C. 69 
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albicans ECE1 (extent of cell elongation) is highly expressed by hyphae during epithelial 70 
infection (Extended Data Fig. 1a, b) and is predicted to encode a secreted protein9.  To probe 71 
its function we generated a panel of C. albicans ECE1-mutants (Extended Data Table 2). The 72 
ece1Δ/Δ strain formed normal hyphae (Extended Data Fig. 1c), and adhered to and invaded 73 
human epithelial cells similarly to wild type C. albicans (Extended Data Fig. 1d, e).  Indeed, 74 
ece1Δ/Δ was capable of extensive epithelial invasion, penetrating through epithelial cells 75 
(Extended Data Fig. 1f).  Despite this, invasive ece1Δ/Δ hyphae did not damage epithelia or 76 
induce p-MKP1/c-Fos mediated danger responses or cytokine secretion (Fig. 1a-d).  Thus, 77 
Ece1p is critical for epithelial damage and innate recognition of C. albicans hyphae in vitro. 78 
We next assessed the role of ECE1 in two in vivo models of C. albicans mucosal 79 
infection. In murine oropharyngeal candidiasis (OPC)10, mice infected with C. albicans wild 80 
type or ECE1 re-integrant (ece1Δ/Δ+ECE1) strains exhibited disease symptoms, including 81 
extensive hyphal invasion of the tongue epithelium, micro-abscesses of infiltrating neutrophils 82 
and tissue damage (Fig. 1e, f, h, i).  In contrast, tongue tissue from ece1Δ/Δ-infected animals 83 
(n = 17/20) showed no invasive fungi and no inflammatory infiltrates or damage (Fig. 1g).  We 84 
detected very low numbers of ece1Δ/Δ in only 3/20 mice (Extended Data Fig. 2a), which 85 
showed no evidence of local epithelial damage (not shown).  Quantification of histology 86 
sections indicated that the percentage of epithelial surface infected was significantly greater 87 
with the wild type and ECE1 re-integrant strains (Extended Data Fig. 2b).  In a zebrafish 88 
swimbladder model of mucosal infection11,12, neutrophil recruitment and tissue damage were 89 
both significantly lower following ece1Δ/Δ infection as compared with the wild type strain 90 
(Fig. 1j, k, Extended Data Fig. 2c, d).  Therefore, C. albicans Ece1p is critical for mucosal 91 
pathogenesis and is an innate immune activator in vivo. 92 
Ece1p is an in vitro substrate for Kex2p, a Golgi-located protease that cleaves proteins 93 
after lysine-arginine (KR) motifs13.  Ece1p contains seven KR-processing sites, indicating that 94 
eight peptides are produced and secreted from C. albicans13 (Extended Data Fig. 3a, b).  Liquid 95 
chromatography–mass spectrometry (LC-MS/MS) analysis confirmed that rKex2p processes 96 
rEce1p and all eight peptides terminating in KR (and fragments thereof, showing that less 97 
efficient processing occurs also after a single K or R) are generated (Supplementary 98 
information).  To determine which Ece1p peptide(s) were responsible for epithelial activation 99 
and damage, oral epithelial cells were incubated with peptides Ece1-I-VIII (1.5 – 70 µM).  Only 100 
Ece1-III62-93 induced p-MKP1, c-Fos, cytokines and damage (Fig. 2a-c, Extended Data Fig. 3c-101 
e).  Notably, low Ece1-III62-93 concentrations (1.5 – 15 µM) were sufficient to induce c-Fos 102 
DNA binding (Fig. 2d), G-CSF and GM-CSF (Fig. 2b, Extended Data Fig. 3c), while high 103 
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Ece1-III62-93 concentrations (70 µM) were required to induce damage (Fig. 2e) and the damage-104 
associated cytokines IL-1α and IL-6, respectively (Extended Data Fig. 3d, e).  Ece1-III62-93 105 
could also directly lyse multiple human epithelial cell types and induce hemolysis of red blood 106 
cells, a classical test for cytotoxin activity (not shown).  Neither the N-terminal hydrophobic 107 
region (Ece1-III62-85) nor the C-terminal hydrophilic region (Ece1-III86-93) induced p-MKP1, c-108 
Fos, cytokines or damage of epithelial cells, either individually or in combination (Extended 109 
Data Fig. 3f-h), demonstrating that the peptide containing both regions is required for activity.  110 
Therefore, Ece1-III62-93 is the active region of Ece1p, acting as an epithelial immune activator 111 
and a cytolytic agent. 112 
To confirm that Ece1-III62-93 drives epithelial activation and fungal pathogenicity, we 113 
generated a C. albicans strain lacking only the Ece1-III62-93 region (ece1Δ/Δ+ECE1Δ184-279).  114 
This strain expressed the mutated ECE1 gene and, like ece1Δ/Δ, efficiently formed invasive 115 
hyphae (not shown). However, ece1Δ/Δ+ECE1Δ184-279 was unable to induce p-MKP1, c-Fos 116 
DNA binding, cytokines, or damage epithelia (Fig. 2f-i).  In murine OPC, unlike the 117 
ece1Δ/Δ+ECE1 recomplemented strain, ece1Δ/Δ+ECE1Δ184-279-infected mice demonstrated 118 
absent (n = 4/10) or low (n = 6/10) fungal burdens, with no evidence of inflammatory infiltrates 119 
or local epithelial damage (Fig. 2j-l, Extended Data Fig. 4a and 4b) Likewise, 120 
ece1Δ/Δ+ECE1Δ184-279 did not induce full damage in the zebrafish swimbladder model (Fig. 121 
2m, Extended Data Fig. 4c).  In contrast, injection of lytic doses of Ece1-III62-93 into the 122 
swimbladder induced epithelial damage (Fig. 2n, o).  Thus, Ece1-III62-93 is both necessary and 123 
sufficient for epithelial immune activation, damage and mucosal infection in vivo.  The 124 
amphipathic properties of Ece1-III62-93 (SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKR) 125 
coupled with the α-helical structure of the N-terminal hydrophobic region (Extended Data Fig. 126 
5a, b) indicated that this fungal peptide may act similarly to cationic antimicrobial peptides and 127 
peptide toxins such as melittin14 (honey bee), magainin 215 (African clawed frog) and 128 
alamethicin16 (Trichoderma viride).  Cytolytic peptide toxins have not previously been found 129 
in human pathogenic fungi but bacterial cytolytic toxins are known to induce lesions after 130 
binding to target cell membranes1.  To investigate the importance of lipid composition for 131 
Ece1-III62-93-mediated cytolysis, we used Förster resonance energy transfer (FRET) and 132 
electrical impedance spectroscopy to analyze the interactions of Ece1-III62-93 with model 133 
membranes comprised of lipid bilayers of dioleoylphosphatidylcholine (DOPC) with or 134 
without cholesterol.  While Ece1-III62-93 was able to efficiently intercalate into and 135 
permeabilize DOPC membranes, Ece1-III62-93 permeabilization was enhanced in the presence 136 
of cholesterol (Fig. 3a, Extended Data Fig. 5c).  Ece1-III62-93-induced lesions were 137 
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heterogeneous and transient (Extended Data Fig. 5d), indicating that the peptide may damage 138 
target membranes through a ‘carpet-like’ mechanism17.  Patch-clamp analysis of epithelial cells 139 
demonstrated that lesion formation by Ece1-III62-93 is rapid and causes an inward current (Fig. 140 
3b), associated with calcium influx (Fig. 3c).  Similar phenomena occur with bacterial cytolytic 141 
toxins, which are known to trigger cell activation1,2,18. 142 
We postulated that the positively-charged C-terminal KR residues of Ece1-III62-93 might 143 
be critical for interacting with negatively-charged components of host membranes to promote 144 
lesion formation.  Substitution of the KR motif to AA (alanine-alanine; Ece1-III62-93AA) did not 145 
affect membrane intercalation (not shown) but significantly reduced the peptide’s ability to 146 
permeabilize membranes, damage epithelial cells and induce calcium influx (Fig. 3c-e).  Thus, 147 
the positive C-terminus of Ece1-III62-93 is critical for lesion formation and damage induction in 148 
epithelial membranes.  Notably, Ece1-III62-93AA still induced p-MKP1, c-Fos and the non-149 
damage associated cytokine G-CSF (Fig. 3f, g) but not the damage-associated cytokine IL-1α 150 
(Fig. 3h), suggesting that Ece1-III62-93AA can be recognized by epithelial immunity without 151 
without damaging cells. This concept is important as it means that epithelial cells are not only 152 
responding to damage but have evolved to specifically recognise the peptide. 153 
To demonstrate that Ece1-III is generated during epithelial infection, we performed LC-154 
MS/MS analysis on the secretome from wild-type C. albicans hyphae grown in the presence 155 
and absence of epithelial cells (Supplementary information).  Ece1-III was the only peptide 156 
detected in the presence of epithelial cells, indicating that the fungus secretes this toxin during 157 
mucosal infection at high concentrations.  However, most significantly, the predominant form 158 
of secreted Ece1-III terminated in a K residue (SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK; 159 
Ece1-III62-92K) and not KR (SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKR; Ece1-III62-93KR) 160 
(Extended Data Table 4).  In fungi, it is known that following Kex2p processing, many proteins 161 
are subsequently cleaved by Kex1p (also in the Golgi), removing the C-terminal R.  LC-162 
MS/MS analysis on the hyphal secretome of a kex1∆/∆ mutant demonstrated that here the 163 
predominant peptide secreted terminates in KR (not K).  Therefore, Ece1 is also subject to 164 
ordered Kex2p/Kex1p processing.  Accordingly, we confirmed that Ece1-III62-92K functioned 165 
similarly to Ece1-III62-93KR with respect to epithelial cell activation.  Specifically, Ece1-III62-92K 166 
is also α-helical (not shown) and induces c-Fos, p-MKP1, cytokines (IL-1α, G-CSF), damage 167 
(LDH), membrane intercalation and permeabilization, and calcium influx (Fig 4a-g).  Thus, the 168 
dominant peptide secreted from C. albicans hyphae during mucosal infection is Ece1-III62-92K, 169 
which acts as a cytolytic peptide toxin that activates epithelial cells. 170 
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Based on these data, we propose a model of C. albicans mucosal infection whereby 171 
invasive hyphae secrete Ece1-III62-92K into a membrane-bound ‘invasion pocket’19, facilitating 172 
peptide accumulation (Extended Data Fig 6).  During early stages of infection, sub-lytic 173 
concentrations of Ece1-III62-92K induce epithelial immunity by activating the ‘danger response’ 174 
pathway (p-MKP1/c-Fos), alerting the host to the transition from colonizing yeast to invasive, 175 
toxin-producing hyphae.  As infection progresses, Ece1-III62-92K levels accumulate and elicit 176 
direct tissue damage.  Mechanistically, we propose that the asymmetric distribution of charge 177 
along the α-helix of Ece1-III62-92K facilitates correct peptide orientation relative to the host 178 
membrane, enabling intercalation, permeabilization and calcium influx.  In conclusion, our 179 
data identifies C. albicans Ece1-III62-92K as the first cytolytic peptide toxin in a human fungal 180 
pathogen and reveals the molecular mechanisms of epithelial damage and host recognition of 181 
this clinically important fungus. We propose the name ‘Candidalysin’ for this newly discovered 182 
fungal toxin.  183 
 184 
Supplementary Information is available in the online version of the paper. 185 
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Figure Legends 266 
Figure 1|  ECE1 is required for epithelial activation and mucosal C. albicans infection. (a) 267 
Fold change induction of LDH release after 24 h infection of TR146 epithelial cells with C. 268 
albicans wild type (BWP17 + CIp30), ECE1-deletion (ece1Δ/Δ) or ECE1 re-integrant 269 
(ece1Δ/Δ+ECE1) strains (MOI = 0.1). (b) Induction of MKP-1 phosphorylation and c-Fos 270 
production after 2 h infection of TR146 epithelial cells with C. albicans wild type, ece1Δ/Δ or 271 
ece1Δ/Δ+ECE1 strains (MOI = 10). (c) Fold change induction of c-Fos DNA binding after 3 272 
h infection of TR146 epithelial cells with C. albicans wild type, ece1Δ/Δ or ece1Δ/Δ+ECE1 273 
(MOI = 10). (d) Induction of G-CSF production after 24 h infection of TR146 epithelial cells 274 
with C. albicans wild type, ece1Δ/Δ or ece1Δ/Δ+ECE1 (MOI = 0.01). (e-i) PAS stained 275 
sections of tongues from OPC-infected mice 2 d post-infection. (e) Whole-mount (original 276 
magnification x25) and (f) high-power (original magnification x200) views of PAS stained 277 
tongue sections from C. albicans wild type infected mice. Foci of infection in (e) are indicated 278 
by asterisks and a high power (x200) view of one of these foci is shown in (f), demonstrating 279 
the presence of invading hyphae (black arrow) and associated infiltrating inflammatory cells 280 
(blue arrow). (g) Whole-mount (original magnification x25) view of a PAS stained tongue 281 
section from a C. albicans ece1Δ/Δ-infected mouse, demonstrating no foci of infection. (h) 282 
Whole-mount (original magnification x25) view of a PAS stained tongue section from a C. 283 
albicans ece1Δ/Δ+ECE1-infected mouse. Foci of infection are indicated by asterisks; (i) High-284 
power (x200) view of a focus of infection, demonstrating invading hyphae (black arrow) and 285 
inflammatory infiltrate (blue arrow), as seen in wild type infected mice. (j) Quantification of 286 
invading neutrophils at the site of infection (SOI) in a zebrafish swimbladder model after 287 
infection with C. albicans wild type (n = 47) or ece1Δ/Δ (n = 53) or PBS (vehicle, n = 40). (k) 288 
Quantification of damaged cells at the site of infection in a zebrafish swimbladder model after 289 
infection with C. albicans wild type (n = 73) or ece1Δ/Δ (n = 59) or PBS (vehicle, n = 63). 290 
Data are representative (b, e-i) or the mean (a, c-d, j-k) of at least three independent 291 
experiments and, where appropriate, error bars show ± SEM. * = P < 0.05, ** = P < 0.01, *** 292 
= P < 0.001. 293 
 294 
Figure 2|  Ece1-III62-93 is the active region of Ece1p and is required for epithelial activation 295 
and mucosal C. albicans infection. (a) Phosphorylation of MKP-1 and production of c-Fos 296 
after 2 h stimulation of TR146 epithelial cells with the eight Ece1 peptides at 1.5 µM. (b) 297 
Induction of G-CSF after stimulation of TR146 epithelial cells for 24 h with varying 298 
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concentrations (70 µM - 1.5 µM) of Ece1-III62-93. (c) Fold change induction of LDH release 299 
from TR146 epithelial cells after 24 h stimulation with the eight Ece1 peptides at 70 µM. (d) 300 
Fold change induction of c-Fos DNA binding in TR146 epithelial cells in response to 3 h 301 
stimulation with sub-lytic concentrations (15 µM - 1.5 µM) of Ece1-III62-93. (e) Fold change 302 
induction of LDH release from TR146 epithelial cells after 24 h stimulation with varying 303 
concentrations (70 µM - 1.5 µM) of Ece1-III62-93. (f) Phosphorylation of MKP-1 and production 304 
of c-Fos after 2 h infection of TR146 epithelial cells with C. albicans wild-type (BWP17 + 305 
CIp30), ECE1-deletion (ece1Δ/Δ), ECE1 re-integrant (ece1Δ/Δ+ECE1) or Ece1-III62-93 306 
deletion (ece1Δ/Δ+ECE1Δ184-279) strains (MOI = 10). (g) Fold change induction of c-Fos DNA 307 
binding in TR146 epithelial cells in response to 3 h infection with C. albicans ece1Δ/Δ+ECE1 308 
or ece1Δ/Δ+ECE1Δ184-279 (MOI = 10). (h) Induction of G-CSF secretion after infection of 309 
TR146 epithelial cells for 24 h with C. albicans wild-type (BWP17 + CIp30), ece1Δ/Δ, 310 
ece1Δ/Δ+ECE1 or ece1Δ/Δ+ECE1Δ184-279 (MOI = 0.01). (i) Fold change induction of LDH 311 
release from TR146 epithelial cells after 24 h infection with C. albicans ece1Δ/Δ+ECE1 or 312 
ece1Δ/Δ+ECE1Δ184-279 (MOI = 0.01). (j-l) PAS stained tongue sections from OPC-infected 313 
mice after 2 d infection with (j, k) C. albicans ece1Δ/Δ+ECE1 (x25 and x200) or (l) 314 
ece1Δ/Δ+ECE1Δ184-279. Invading hyphae (black arrows) and infiltrating inflammatory cells 315 
(blue arrow) are shown. (m) Quantification of damaged cells at the site of infection in a 316 
zebrafish swimbladder model after infection with C. albicans ece1Δ/Δ+ECE1 (n = 44) or 317 
ece1Δ/Δ+ECE1Δ184-279 (n = 58) or PBS (vehicle, n = 58). (n-o) Direct damage induced by Ece1-318 
III62-93 in a zebrafish swimbladder model. (n) Quantification of damaged cells in zebrafish 319 
swimbladders after stimulation with 9 ng/fish (n = 51) or 1.25 ng/fish (n = 56) of Ece1-III62-93. 320 
DMSO was the vehicle control (40% DMSO, n = 54 and 5% DMSO, n = 55). (o) Co-321 
localization of adherens junctions (α-catenin-citrine) with Ece1-III62-93-damaged epithelial 322 
cells (Sytox Orange-positive cells) in the swimbladder by intravital imaging of zebrafish. Data 323 
are representative (a, f, j-l, o) or the mean (b-e, g-i, m-n) of at least three independent 324 
experiments (a-m) or ten fish (n-o) and, where appropriate, error bars show ± SEM. * = P < 325 
0.05, ** = P < 0.01, *** = P < 0.001 (compared with vehicle control). 326 
 327 
Figure 3|  Ece1-III62-93 functions as a cytolytic peptide toxin. (a) Raw time-dependent 328 
changes in conductance of tethered lipid membranes. Strong permeabilization by Ece1-III62-93 329 
of pure DOPC membranes and DOPC membranes containing 10% cholesterol. Peptide 330 
concentrations shown on panel. (b) Evoked inward current at a membrane potential of -60 mV 331 
in TR146 epithelial cell membranes after the addition of Ece1-III62-93 (70 µM - 1.5 µM) or 332 
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ionomycin (10 µM, positive control), showing both individual (representative) and cumulative 333 
changes (bar chart - number of cells analysed below each bar). Water was the vehicle control. 334 
(c) Changes in intracellular calcium levels in TR146 epithelial cells over time after stimulation 335 
with Ece1-III62-93 wild type (Ece1-III62-93KR) or Ece1-III62-93 AA C-terminal substitution (Ece1-336 
III62-93AA) at different concentrations (70 µM - 1.5 µM). (d) Raw time-dependent changes in 337 
conductance of tethered DOPC membranes, showing strong permeabilization by Ece1-III62-338 
93KR but extremely weak permeabilization by Ece1-III62-93AA. Peptide concentrations shown on 339 
panel. (e) Fold change induction of LDH release from TR146 epithelial cells after 24 h 340 
stimulation with Ece1-III62-93KR or Ece1-III62-93AA at varying concentrations (70 µM - 1.5 µM). 341 
(f) Phosphorylation of MKP-1 and production of c-Fos after 2 h treatment of TR146 epithelial 342 
cells with Ece1-III62-93KR or Ece1-III62-93AA at varying concentrations (15 µM - 1.5 µM). 343 
Induction of (g) G-CSF and (h) IL-1α secretion from TR146 epithelial cells after 24 h 344 
stimulation with Ece1-III62-93KR or Ece1-III62-93AA at varying concentrations (70 µM - 1.5 µM). 345 
Data shown are representative (a, d, f) or mean (b-c, e, g-h) of at least three independent 346 
experiments and, where appropriate, error bars show ± SEM. * = P < 0.05, ** = P < 0.01, *** 347 
= P < 0.001. 348 
 349 
Figure 4|  Ece1-III62-92K functions as a cytolytic peptide toxin that activates and damages 350 
epithelial cells. (a) Phosphorylation of MKP-1 and production of c-Fos after 2 h stimulation, 351 
and (b) Induction of G-CSF and IL-1-α after 24 h stimulation, and (c) Fold change induction 352 
of LDH after 24 h stimulation of TR146 epithelial cells with varying concentrations (70 µM - 353 
1.5 µM) of Ece1-III62-92K. (d) Förster resonance energy transfer (FRET) experiments showing 354 
the intercalation of Ece1-III62-92K into lipid liposomes (10 µM) composed of DOPC in the 355 
absence or presence of cholesterol. Peptide titration of Ece1-III62-92K to liposomes showed 356 
similar intercalation for both pure DOPC and DOPC containing host cholesterol. (e) Average 357 
peptide concentration-dependent changes in conductance of tethered lipid membranes. Strong 358 
permeabilization by Ece1-III62-92K of pure DOPC membranes, which was increased in the 359 
presence of cholesterol. (f) Ece1-III62-92K induced the permeabilization of planar lipid 360 
membranes composed of DOPC. The graph shows heterogeneous and transient lesions leading 361 
finally to a rupture of the membrane. Ece1-III62-92K concentration was 4 µM. (g) Changes in 362 
intracellular calcium levels in a TR146 epithelial cells over time after stimulation with Ece1-363 
III62-92K at different concentrations (70 µM - 1.5 µM). Data shown are representative (a, d, f) 364 
or mean (b-c, e, g) of at least three independent experiments and, where appropriate, error bars 365 
show ± SEM. * = P < 0.05, ** = P < 0.01, *** = P < 0.001. 366 
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 367 
Extended Data Figure legends 368 
 369 
Extended Data Figure 1:  C. albicans ECE1 expression and phenotypic effects of ECE1 370 
gene deletion. (a) Relative expression (vs t = 0) of ECE1 in C. albicans wild type over time 371 
after addition of yeast cells to TR146 epithelial cells as measured by RT-qPCR. (b) Imaging 372 
confirmation of ECE1 expression over time within C. albicans wild type. C. albicans cells 373 
expressing GFP under the control of the ECE1 5' intragenic region, containing the ECE1 374 
promoter, were grown on TR146 epithelial cells and stained with calcofluor white (CFW, post-375 
permeabilization) to show cell wall chitin and Alexa-Fluor-647-labelled concanavalin A 376 
(ConA, pre-permeabilization) to show carbohydrates. A composite image showing CFW, 377 
ConA, GFP and the brightfield (BF) image is shown. (c) Scanning electron micrographs (top 378 
panels, 5 h) and light microscopy (bottom panels, 24 h) showing no gross abnormalities in 379 
hypha formation between C. albicans wild type (BWP17+CIp30), ECE1-deletion (ece1Δ/Δ) 380 
and ECE1 re-integrant (ece1Δ/Δ+ECE1) strains after infection of TR146 epithelial cells. (d) 381 
No difference in adhesion of C. albicans wild type, ece1Δ/Δ and ece1Δ/Δ+ECE1 strains to 382 
TR146 epithelial cells after 60 min. (e) No difference in invasion of C. albicans wild type, 383 
ece1Δ/Δ and ece1Δ/Δ+ECE1 strains into TR146 epithelial cells after 3 h. (f) Fluorescence 384 
staining of C. albicans wild type and ece1Δ/Δ hyphae invading through TR146 epithelial cells. 385 
Fungal cells are stained with calcofluor white (CFW, post-permeabilization) and Alexa-Fluor-386 
647-labelled concanavalin A (ConA, pre-permeabilization) to show cell wall chitin and 387 
carbohydrates, respectively, and to distinguish between invading hyphae (only stained after 388 
permeabilization) and non-invading hyphae (stained both pre- and post-permeabilization). 389 
Levels of chitin and β-glucan are comparable in both strains. White arrows indicate invasion 390 
into epithelial cells. Data shown are representative (b, c, f) or the mean (a, d, e) of at least three 391 
independent experiments. 392 
 393 
Extended Data Figure 2:  C. albicans Ece1p is critical for mucosal virulence in vivo. (a) 394 
Fungal burdens recovered from the tongues of mice infected with C. albicans wild type 395 
(BWP17+CIp30) (n = 13), ECE1-deletion (ece1Δ/Δ) (n = 20) and ECE1 re-integrant 396 
(ece1Δ/Δ+ECE1) (n = 24) strains after 2 day oropharyngeal infection. The number of animals 397 
in each group is indicated above the bar. (b) Average percentage of the entire tongue epithelium 398 
length infected in different groups of mice infected with the different C. albicans strains. (c) 399 
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Confocal imaging of 4 day post-fertilization (dpf) mpo-gfp transgenic zebrafish swimbladders 400 
infected with C. albicans wild type (BWP17+CIp30+dTomato), ECE1-deletion 401 
(ece1Δ/Δ+dTomato) and ECE1 re-integrant (ece1Δ/Δ+ECE1+dTomato) strains for 24 h. C. 402 
albicans cells appear red whilst neutrophils appear green. Red dots outline the swimbladder. 403 
Images are composites of maximum projections in the red and green channels (25 slices each, 404 
approximately 100 μm depth) with (left) or without (right) a single slice in the DIC channel 405 
overlay. Scale bars represent 100 μm. (d) Confocal imaging of 4 dpf zebrafish swimbladders 406 
infected with C. albicans wild type (BWP17+CIp30+dTomato), ECE1-deletion 407 
(ece1Δ/Δ+dTomato) and ECE1 re-integrant (ece1Δ/Δ+ECE1+dTomato) strains for 24 h 408 
stained with the fluorescent exclusion dye Sytox Green. C. albicans cells appear red and 409 
damaged epithelial cells appear green. White dots outline the pronephros and red dots outline 410 
the swimbladder. Images are composites of maximum projections in the red and green channels 411 
(25 slices each, approximately 100 μm depth) with (left) or without (right) a single slice in the 412 
DIC channel overlay. High magnification images of the white boxes are shown. Scale bars 413 
represent 100 μm (low magnification) and 30 μm (high magnification). Data shown are the 414 
mean (a) or representative (b, c) of at least three independent experiments. Where appropriate, 415 
error bars show ± SEM. *** = P < 0.001. 416 
 417 
Extended Data Figure 3: Ece1-III62-93 is the active region of Ece1p. (a) Amino acid 418 
sequence of Ece1p and a schematic of the protein, indicating the signal peptide (SP), lysine-419 
arginine motifs (KR) at the C-terminus of each peptide, and the processed peptides (Ece1-I-420 
VIII) produced by Kex2p cleavage. (b) Amino acid sequences of the processed peptides (Ece1-421 
I-VIII) produced by Kex2p cleavage. Induction of (c) GM-CSF, (d) IL-1α and (e) IL-6 secreted 422 
after stimulation of TR146 epithelial cells for 24 h with varying concentrations of Ece1-III62-93 423 
(70 µM - 1.5 µM). (f) Phosphorylation of MKP-1 and c-Fos production after 2 h treatment of 424 
TR146 epithelial cells with 15 µM of Ece1-III62-85 (hydrophobic region), Ece1-III86-93 425 
(hydrophillic region), Ece1-III62-85 and Ece1-III86-93 together, or Ece1-III62-93 alone. (g) 426 
Induction of G-CSF secretion after 24 h treatment of TR146 epithelial cells with 15 µM of 427 
Ece1-III62-85, Ece1-III86-93, Ece1-III62-85 and Ece1-III86-93 together, or Ece1-III62-93 alone. (h) 428 
Fold change induction of LDH release after 24 h treatment of TR146 epithelial cells with 70 429 
µM of Ece1-III62-85, Ece1-III86-93, Ece1-III62-85 and Ece1-III86-93 together, or Ece1-III62-93 alone. 430 
Data shown are representative (f) or the mean (c-e, g-h) of at least three independent 431 
experiments. Where appropriate, error bars show ± SEM. * = P < 0.05, ** = P < 0.01, *** = P 432 
< 0.001 (compared with vehicle control). 433 
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 434 
Extended Data Figure 4: Ece1-III62-93 is required for C. albicans mucosal infection. (a) 435 
Fungal burdens recovered from the tongues of mice infected with C. albicans wild type 436 
(BWP17+CIp30) (n = 13), ECE1-deletion (ece1Δ/Δ) (n = 20), ECE1 re-integrant 437 
(ece1Δ/Δ+ECE1) (n = 24) and Ece1-III62-93 deletion (ece1Δ/Δ+ECE1Δ184-279) (n = 10) strains 438 
after 2 day oropharyngeal infection. (b) Average percentage of the entire tongue epithelium 439 
length infected in different groups of mice infected with the different C. albicans strains. (c) 440 
Confocal imaging of 4 dpf zebrafish swimbladders infected with C. albicans Ece1-III62-93 441 
deletion (ece1Δ/Δ+ECE1Δ184-279+dTomato) and ECE1 re-integrant 442 
(ece1Δ/Δ+ECE1+dTomato) strains for 24 h stained with the fluorescent exclusion dye Sytox 443 
Green. C. albicans cells appear red and damaged cells appear green. White dots outline the 444 
pronephros and red dots outline the swimbladder. Images are composites of maximum 445 
projections in the red and green channels (25 slices each, approximately 100 μm depth) with 446 
(left) or without (right) a single slice in the DIC channel overlay. Scale bars represent 100 μm. 447 
Data shown are the mean (a) or representative (b, c) of at least three independent experiments. 448 
Where appropriate, error bars show ± SEM. ** = P < 0.01, *** = P < 0.001. 449 
 450 
Extended Data Figure 5: Ece1-III62-93 is a cytolytic α-helical peptide. (a) Circular dichroism 451 
spectra showing the α-helical conformation of Ece1-III62-93 in buffer (100 mM KCl, 5 mM 452 
HEPES, pH 7). Increasing the temperature from 25oC to 40oC did not affect the stability of the 453 
α-helical structure. (b) Diagram to illustrate the amphipathic nature of Ece1-III62-93 (residues 454 
62-78, left panel; residues 79-93, right panel). Residues with hydrophobic or polar/charged side 455 
chains are displayed with a blue and white background, respectively. Modified from output 456 
generated in PEPWHEEL (http://emboss.bioinformatics.nl/cgi-bin/emboss/pepwheel). (c) 457 
Förster resonance energy transfer (FRET) experiments show the intercalation of Ece1-III62-93 458 
into lipid liposomes (10 µM) composed of DOPC in the absence or presence of cholesterol. 459 
Peptide titration of Ece1-III62-93 to liposomes showed slightly enhanced intercalation for pure 460 
DOPC. (d) Ece1-III62-93 induced the permeabilization of planar lipid membranes composed of 461 
DOPC. The graph shows heterogeneous and transient lesions leading finally to a rupture of the 462 
membrane. Ece1-III62-93 concentration was 0.125 µM. 463 
 464 
Extended Data Figure 6: Schematic of the role of Ece1-III in C. albicans infection of 465 
epithelial cells. During early stage infection of the mucosal surface by C. albicans, Ece1-III 466 
(red α-helix) is secreted into the invasion pocket created by the invading hypha (a). Sub-lytic 467 
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concentrations of Ece1-III trigger epithelial signal transduction through MAPK, p38/MKP-1 468 
and c-Fos (b) resulting in the production of immune regulatory cytokines (c). As the severity 469 
of the infection increases, Ece1-III accumulates (d) and once lytic concentrations are reached, 470 
causes membrane damage and the release of lactate dehydrogenase from the host epithelium 471 
(e), concomitant with calcium influx (f). Epithelial signal transduction is maintained (g) and 472 
additionally induces the release of damage associated cytokines, such as IL-1α (h). Ece1-III 473 
may also have activity on the epithelial surface outside of the invasion pocket and on 474 
neighbouring cells not in contact with hyphae if Ece1-III is produced in sufficient 475 
concentrations. 476 
  477 
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METHODS 478 
 479 
Cell lines, reagents and Candida strains 480 
Experiments were carried out using the TR146 buccal epithelial squamous cell carcinoma line20 481 
grown in Dulbecco's Modified Eagle's Medium (DMEM, Sigma-Aldrich) supplemented with 482 
10% fetal bovine serum (FBS) and 1% penicillin-streptomycin. Prior to stimulation, confluent 483 
TR146 epithelial cells were serum-starved overnight, and all experiments were carried out in 484 
serum-free DMEM. C. albicans wild type strains included the autotrophic strain 485 
BWP17+CIp3021 and the parental strain SC531422. Other C. albicans strains used and their 486 
sources are listed in Extended Data Tables 1 and 2. C. albicans cultures were grown in YPD 487 
medium (1% yeast extract, 2% peptone, 2% dextrose) at 30°C overnight. Cultures were washed 488 
in sterile PBS and adjusted to the required cell density. Antibodies to phospho-MKP1 and c-489 
Fos were from Cell Signalling Technologies (New England Biolabs UK), mouse anti-human 490 
α-actin was from Millipore (UK), and goat anti-mouse and anti-rabbit horseradish peroxidase 491 
(HRP)-conjugated antibodies were from Jackson Immunologicals Ltd (Stratech Scientific, 492 
UK). Ece1p peptides were synthesised commercially (Proteogenix (France) or 493 
PeptideSynthetics (UK).  494 
 495 
Generation of C. albicans ECE1 mutant strains 496 
ECE1 deletion was performed as previously described23. Deletion cassettes were generated by 497 
PCR24. Primers ECE1-FG and ECE1-RG were used to amplify pFA-HIS1 and pFA-ARG4 -498 
based markers. C. albicans BWP1725, was sequentially transformed26 with the ECE1-HIS1 and 499 
ECE1-ARG4 deletion cassettes and then transformed with CIp1027, yielding the ece1∆/Δ 500 
deletion strain. For complementation, the ECE1 gene plus upstream and downstream intergenic 501 
regions were amplified with primers ECE1-RecF3k and ECE1-RecR and cloned into plasmid 502 
CIp108 at MluI and SalI sites. This plasmid was transformed into the uridine auxotrophic 503 
ece1Δ/Δ strain, yielding the ece1∆/Δ+ECE1 complemented strain. For generation of the 504 
ece1Δ/Δ+ECE1∆184-279 strain, the CIp10-ECE1 was amplified with primers Pep3-F1 and Pep3-505 
R127, yielding the CIp10+ECE1Δ184-279 plasmid. This plasmid was transformed into the uridine 506 
auxotrophic ece1Δ/Δ strain, yielding the ece1Δ/Δ+ECE1∆184-279 strain. All integrations were 507 
confirmed by PCR/sequencing and at least two independent isogenic transformants were 508 
created to confirm results. KEX1 deletion was performed exactly as the ECE1 deletion but 509 
using primers KEX1-FG and KEX1-RG for creating the deletion cassette. Fluorescent strains 510 
of ece1Δ/Δ and BWP17 were constructed as previously described28. Briefly, the ece1Δ/Δ and 511 
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BWP17 strains were transformed with the pENO1-dTom-NATr plasmid. Primers used to clone 512 
and construct the ECE1 genes and intragenic regions are listed in Extended Data Table 3. 513 
Strains are listed in Extended Data Table 2. 514 
 515 
Construction of C. albicans ECE1 promoter-GFP strain 516 
ECE1 promoter (primers 5'ECE1prom-NarI / 3'ECE1prom-XhoI) and terminator 517 
(5'ECE1term-SacII / 5'ECE1term-SacI) were amplified and cloned into pADH1-GFP. 518 
Resulting pSK-pECE1-GFP was verified by sequencing. C. albicans SC5314 was transformed 519 
with the pECE1-GFP transformation cassette26. Resistance to nourseothricin was used as 520 
selective marker and correct integration of GFP into the ECE1 locus was verified by PCR. 521 
Primers for cloning and validation are listed in Extended Data Table 3. Strains are listed in 522 
Extended Data Table 2. 523 
 524 
RNA isolation and real-time PCR analysis 525 
C. albicans cells grown on TR146 epithelial cells were collected into RNA pure (PeqLab), 526 
centrifuged and the pellet resuspended in 400 µl AE buffer (50 mM Na-acetate pH 5.3, 10 mM 527 
EDTA, 1% SDS). Samples were vortexed (30 s), and an equal volume of 528 
phenol/chloroform/isoamyl alcohol (25:24:1) was added and incubated for 5 min (65°C) before 529 
subjected to 2x freeze-thawing. Lysates were clarified by centrifugation and the RNA 530 
precipitated with isopropyl alcohol/0.3 M sodium acetate by incubating for 1 h at -20°C. 531 
Precipitated pellets were washed (2x 1 ml 70% ice-cold ethanol), resuspended in DEPC-treated 532 
water and stored at -80°C. RNA integrity and concentration was confirmed using a Bioanalyzer 533 
(Agilent). RNA (500 ng) was treated with DNase (Epicenter) and cDNA synthesized using 534 
Reverse Transcriptase Superscript III (Invitrogen). cDNA samples were used for qPCR with 535 
EVAgreen mix (Bio&Sell). Primers (ACT1-F and ACT1-R for actin, ECE1-F and ECE1-R for 536 
ECE1 - Extended Data Table 3) were used at a final concentration of 500 nM. qPCR 537 
amplifications were performed using a Biorad CFX96 thermocycler. Data was evaluated using 538 
Bio-Rad CFX Manager 3.1 (Bio-Rad) with ACT1 as the reference gene and t0 as the control 539 
sample. 540 
 541 
Western blotting 542 
TR146 cells were lysed using a modified RIPA lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM 543 
NaCl, 1 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS) containing 544 
protease (Sigma-Aldrich) and phosphatase (Perbio Science) inhibitors29, left on ice (30 min) 545 
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and then clarified (10 min) in a refrigerated microfuge. Lysate total protein content was 546 
determined using the BCA protein quantitation kit (Perbio Science).  20 µg of total protein was 547 
separated on 12% SDS-PAGE gels before transfer to nitrocellulose membranes (GE 548 
Healthcare). After probing with primary (1:1000) and secondary (1:10,000) antibodies, 549 
membranes were developed using Immobilon chemiluminescent substrate (Millipore) and 550 
exposed to X-Ray film (Fuji film). Human α-actin was used as a loading control. 551 
 552 
Transcription factor DNA binding assay 553 
DNA binding activity of transcription factors was assessed using the TransAM transcription 554 
factor ELISA system (Active Motif) as previously described29,30. Serum-starved TR146 555 
epithelial cells were treated for 3 h before being differentially lysed to recover nuclear proteins 556 
using a nuclear protein extraction kit (Active Motif) according to the manufacturer's protocol. 557 
Protein concentration was determined (BCA protein quantitation kit (Perbio Science)) and 5 558 
µg of nuclear extract was assayed in the TransAM system according to the manufacturer’s 559 
protocol. Data was expressed as fold-change in A450nm relative to resting cells. 560 
 561 
Cytokine determination 562 
Cytokine levels in cell culture supernatants were determined using the Performance magnetic 563 
Fluorokine MAP cytokine multiplex kit (Bio-techne) and a Bioplex 200 machine. The data 564 
were analysed using Bioplex Manager 6.1 software to determine analyte concentrations. 565 
 566 
Cell damage assay 567 
Following incubation, culture supernatant was collected and assayed for lactate dehydrogenase 568 
(LDH) activity using the Cytox 96 Non-Radioactive Cytotoxicity Assay kit (Promega) 569 
according to the manufacturer’s instructions. Recombinant porcine LDH (Sigma-Aldrich) was 570 
used to generate a standard curve. 571 
 572 
Epithelial adhesion assay 573 
Quantification of C. albicans adherence to TR146 epithelial cells was performed as described 574 
previously31. Briefly, TR146 cells were grown to confluence on glass coverslips for 48 h in 575 
tissue culture plates in DMEM medium. C. albicans yeast cells (2 x 105) were added into 1 ml 576 
serum-free DMEM, incubated for 60 min (37C/5% CO2) and non-adherent C. albicans cells 577 
removed by aspiration. Following washing (3x 1 ml PBS), cells were fixed with 4% 578 
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paraformaldehyde (Roth) and adherent C. albicans cells stained with Calcofluor White and 579 
quantified using fluorescence microscopy. The number of adherent cells was determined by 580 
counting 100 high power fields of 200 µm × 200 µm size. Exact total cell numbers were 581 
calculated based on the quantified areas and the total size of the cover slip. 582 
 583 
Epithelial invasion assay 584 
C. albicans invasion of epithelial cells was determined as described previously31. Briefly, 585 
TR146 epithelial cells were grown to confluence on glass coverslips for 48 h and then infected 586 
with C. albicans yeast cells (1×105), for 3 h in a humidified incubator (37C/5% CO2). 587 
Following washing (3x PBS), the cells were fixed with 4% paraformaldehyde. All surface 588 
adherent fungal cells were stained for 1 h with a rabbit anti-Candida antibody and subsequently 589 
with a goat anti-rabbit-Alexa Fluor 488 antibody. After rinsing with PBS, epithelial cells were 590 
permeabilised (0.1% Triton X-100 in PBS for 15 min) and fungal cells (invading and non-591 
invading) were stained with Calcofluor White. Following rinsing with water, coverslips were 592 
visualized using fluorescence microscopy. The percentage of invading C. albicans cells was 593 
determined by dividing the number of (partially) internalized cells by the total number of 594 
adherent cells. At least 100 fungal cells were counted on each coverslip. 595 
 596 
Imaging of C. albicans growth and invasion of epithelial cells 597 
TR146 cells (105/ml) seeded on glass coverslips in DMEM/10% FBS were infected with C. 598 
albicans (2.5 x 104 cfu/ml) in DMEM and incubated for 6 h (37°C/5% CO2). Cells were washed 599 
with PBS, fixed overnight (4°C in 4% paraformaldehyde) and stained with Concanavalin A-600 
Alexa Fluor 647 in PBS (10 µg/ml) for 45 min at room temperature in the dark with gentle 601 
shaking (70 rpm) to stain the fungal cell wall. Epithelial cells were permeabilised with 0.1% 602 
Triton X-100 for 15 min at 37°C in the dark, then washed and stained with 10 µg/ml Calcofluor 603 
White (0.1 M Tris-HCl pH 9.5) for 20 min at room temperature in the dark with gentle shaking. 604 
Cells were rinsed in water and mounted on slides with 6 µl of ProLong Gold antifade reagent, 605 
before air drying for 2 h in the dark. Fluorescence microscopy was performed on a Zeiss Axio 606 
Observer Z1 microscope, and 5 phase images were taken per picture.  607 
 608 
Scanning Electron Microscopy 609 
For scanning electron microscopy (SEM) analysis, TR146 cells were grown to confluence on 610 
Transwell inserts (Greiner) and serum starved overnight in serum-free DMEM. After 5 h of C. 611 
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albicans incubation on epithelial cells at an MOI of 0.01, cell media was removed and samples 612 
were fixed overnight at 4oC with 2.5% (v/v) glutaraldehyde in 0.05 M HEPES buffer (pH 7.2) 613 
and post-fixed in 1% (w/v) osmium tetroxide for 1 h at room temperature. After washing, 614 
samples were dehydrated through a graded ethanol series before being critical point dried 615 
(Polaron E3000, Quorum Technologies Ltd). Dried samples were mounted using carbon 616 
double side sticky discs (TAAB) on aluminium pins (TAAB) and gold coated in an Emitech 617 
K550X sputter coater (Quorum Technologies Ltd). Samples were examined and images 618 
recorded using a FEI Quanta 200 field emission scanning electron microscope operated at 3.5 619 
kV in high vacuum mode. 620 
 621 
Zebrafish swimbladder mucosal infection model 622 
Ten to twenty zebrafish per group per experiment (‘n’ in each figure legend) were maintained 623 
at 33°C in E3 + PTU and used as previously described28. Briefly, 4 day post-fertilization (dpf) 624 
larvae were treated with 20 μg/ml dexamethasone dissolved in 0.1% DMSO 1 h prior to 625 
infection and thereafter. For tissue damage and neutrophil recruitment, individual AB or 626 
mpo:GFP fish (respectively) were injected into the swimbladder with 4 nl of PBS with/without 627 
25-40 C. albicans yeast cells of ece1Δ/Δ-dTomato or BWP17-dTomato. For tissue damage, 1 628 
nl of Sytox green (0.05 mM in 1% DMSO) was injected at 20 h post-infection into the 629 
swimbladder and fish were imaged by confocal microscopy at 24 h post-infection. For 630 
neutrophil recruitment, fish were imaged at 24 h post-injection. For synthetic peptide damage, 631 
AB or α-catenin:citrine32 fish were injected with 2 nl of peptide (9 ng or 1.25 ng per fish) or 632 
vehicle (40% DMSO or 5% DMSO) + SytoxGreen (0.05 mM in 1% DMSO) or SytoxOrange 633 
(0.5 mM in 10% DMSO) and the fish imaged by confocal microscopy 4 h later. Numbers of 634 
neutrophils and damaged cells observed were counted and tabulated for each fish. 635 
 636 
Zebrafish swimbladder fluorescence microscopy 637 
Live zebrafish imaging was carried out as previously described28. Briefly, fish were 638 
anesthetized in Tris-buffered Tricaine (200 μg/ml, Western Chemicals) and further 639 
immobilized in a solution of 0.4% low-melting-point agarose (LMA, Lonza) in E3 + Tricaine 640 
in a 96-well plate glass-bottom imaging dish (Greiner Bio-On). Confocal imaging was carried 641 
out using an Olympus IX-81 inverted microscope with an FV-1000 laser scanning confocal 642 
system (Olympus). Images were collected and processed using Fluoview (Olympus) and 643 
Photoshop (Adobe Systems Inc.). Panels are either a single slice for the differential interference 644 
contrast channel (DIC) with maximum projection overlays of fluorescence image channels 645 
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(red-green), or maximum projection overlays of fluorescence channels. The number of slices 646 
for each maximum projection is specified in the legend of individual figures. 647 
 648 
Murine oropharyngeal candidiasis model 649 
A previously described murine model of oropharyngeal candidiasis using female Balb/c mice33 650 
was modified for investigating early infection events. Briefly, mice were treated sub-651 
cutaneously with 3 mg/mouse (in 200 µl PBS with 0.5% Tween 80) of cortisone acetate on 652 
days -1 and 1 post-infection. On day 0, mice were sedated for ~75 min with an intra-peritoneal 653 
injection of 110 mg/kg ketamine and 8 mg/kg xylazine, and a swab soaked in a 107 cfu/ml C. 654 
albicans yeast culture in sterile saline was placed sub-lingually for 75 min. After 2 days, mice 655 
were sacrificed, the tongue excised and divided longitudinally in half. One half was weighed, 656 
homogenized and cultured to derive quantitative Candida counts. The other half was processed 657 
for histopathology and immunohistochemistry. 658 
 659 
Immunohistochemistry of murine tissue 660 
C. albicans infected murine tongues were fixed in 10% (v/v) formal-saline before being 661 
embedded and processed in paraffin wax using standard protocols. For each tongue, 5 µm 662 
sections were prepared using a Leica RM2055 microtome and silane coated slides. Sections 663 
were dewaxed using xylene, before C. albicans and infiltrating inflammatory cells were 664 
visualised by staining using Periodic Acid-Schiff (PAS) stain and counterstaining with 665 
haematoxylin. Sections were then examined by light microscopy. 666 
 667 
Whole cell patch clamp 668 
TR146 epithelial cells were grown in 35 mm petri dishes (Nunc) for 48 h before recordings at 669 
low cell density (10-30% confluence). Cells were superfused with a modified Krebs solution 670 
(120 mM NaCl, 3 mM KCl, 2.5 mM CaCl2, 1.2 mM MgCl2, 22.6 mM NaHCO2, 11.1 mM 671 
glucose, 5 mM HEPES pH 7.4). Isolated cells were recorded at room temperature (21-23oC) in 672 
whole cell mode using microelectrodes (5-7 MΩ) containing 90 mM potassium acetate, 20 mM 673 
KCl, 40 mM HEPES, 3 mM EGTA, 3 mM MgCl2, 1 mM CaCl2 (free Ca2+ 40 nM), pH 7.4. 674 
Cells were voltage clamped at -60 mV using an Axopatch 200A amplifier (Axon Instruments) 675 
and current/voltage curves were generated by 1 s steps between -100 to + 50 mV. Treatments 676 
were applied to the superfusate to produce the final required concentration, with vehicle 677 
controls similarly applied. Data was recorded using Clampex software (PClamp 6, Axon 678 
Instrument) and analyzed with Clampfit 10. 679 
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 680 
Calcium flux 681 
TR146 cells were grown in a 96-well plate overnight until confluent. The medium was removed 682 
and 50 µl of a Fura-2 solution (5 µl Fura-2 (Life Technologies)(2.5 mM in 50% Pluronic F-683 
127 (Life technologies):50% DMSO), 5 µl probenecid (Sigma) in 5 ml saline solution (NaCl 684 
(140 mM), KCl (5 mM), MgCl2 (1 mM), CaCl2 (2 mM), Glucose (10 mM) and HEPES (10 685 
mM), adjusted to pH 7.4)) was added and the plate incubated for 1 h at 37°C/5% CO2. The 686 
Fura-2 solution was replaced with 50 µl saline solution and baseline fluorescence readings 687 
(excitation 340 nm/emission 520nm) taken for 10 min using a FlexStation 3 (Molecular 688 
Devices). Ece1 peptides were added at different concentrations and readings immediately taken 689 
for up to 3 h. The data was analyzed using Softmax Pro software to determine calcium present 690 
in the cell cytosol and expressed as the ratio between excitation and emission spectra. 691 
 692 
Impedance spectroscopy of tethered bilayer lipid membranes (tBLMs) 693 
tBLMs with 10% tethering lipids and 90% spacer lipids (T10 slides) were formed using the 694 
solvent exchange technique34,35 according to the manufacturer’s instructions (SDx Tethered 695 
Membranes Pty Ltd, Sydney, Australia). Briefly, 8 µl of 3 mM lipid solutions in ethanol were 696 
added, incubated for 2 min and then 93.4 µl buffer (100 mM KCl, 5 mM HEPES, pH 7.0) was 697 
added. After rinsing 3x with 100 µl buffer the conductance and capacitance of the membranes 698 
were measured for 20 min before injection of Ece1 peptides at different concentrations. All 699 
experiments were performed at room temperature. Signals were measured using the tethaPod 700 
(SDx Tethered Membranes Pty Ltd, Sydney, Australia). 701 
 702 
FRET intercalation experiments 703 
Intercalation of Ece1 peptides into phospholipid liposomes was determined by FRET 704 
spectroscopy applied as a probe-dilution assay36. Phospholipids mixed with each 1% (mol/mol) 705 
of the donor dye NBD-phosphatidylethanolamine (NBD-PE) and of the acceptor dye 706 
rhodamine-PE, were dissolved in chloroform, dried, solubilized in 1 ml buffer (100 mM KCl, 707 
5 mM HEPES, pH 7.0) by vortexing, sonicated with a titan tip (30 W, Branson sonifier, cell 708 
disruptor B15), and subjected to three cycles of heating to 60°C and cooling down to 4°C, each 709 
for 30 min. Lipid samples were stored at 4°C for at least 12 h before use. Ece1 peptide was 710 
added to liposomes and intercalation was monitored as the increase of the quotient between the 711 
donor fluorescence intensity ID at 531 nm and the acceptor intensity IA at 593 nm (FRET signal) 712 
independent of time. 713 
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 714 
Circular Dichroism spectroscopy 715 
CD measurements were performed using a Jasco J-720 spectropolarimeter (Japan 716 
Spectroscopic Co., Japan), calibrated as described previously37. CD spectra represent the 717 
average of four scans obtained by collecting data at 1 nm intervals with a bandwidth of 2 nm. 718 
The measurements were performed in 100 mM KCl, 5 mM HEPES, pH 7.0 at 25°C and 40°C 719 
in a 1.0 mm quartz cuvette. The Ece1-III concentration was 15 µM. 720 
 721 
Planar lipid bilayers 722 
Planar lipid bilayers were prepared using the Montal-Mueller technique38 as described 723 
previously39. All measurements were performed in 5 mM HEPES, 100 mM KCl, pH 7.0 724 
(specific electrical conductivity 17.2 mS/cm) at 37°C. 725 
 726 
Hyphal secretome preparation for LC-MS/MS analysis 727 
Candida strains were cultured for 18 h in hyphae inducing conditions (YNB medium 728 
containing 2% sucrose, 75 mM MOPSO buffer pH 7.2, 5 mM N-acetyl-D-glucosamine, 37°C). 729 
Hyphal supernatants were collected by filtering through a 0.2 µm PES filter, and peptides were 730 
enriched by Solid Phase Extraction (SPE) using first C4 and subsequently C18 columns on the 731 
C4 flowthrough. After drying in a vacuum centrifuge, samples were resolubilised in loading 732 
solution (0.2% formic acid in 71:27:2 ACN/H2O/DMSO (v/v/v)) and filtered through a 10 kDa 733 
MWCO filter. The filtrate was transferred into HPLC vials and injected into the LC-MS/MS 734 
system. LC-MS/MS analysis was carried out on an Ultimate 3000 nano RSLC system coupled 735 
to a QExactive Plus mass spectrometer (ThermoFisher Scientific). Peptide separation was 736 
performed based on a direct injection setup without peptide trapping using an Accucore C4 737 
column as stationary phase and a column oven temperature of 50°C. The binary mobile phase 738 
consisting of A) 0.2% (v/v) formic acid in 95:5 H2O/DMSO (v/v) and B) 0.2% (v/v) formic 739 
acid in 85:10:5 ACN/H2O/DMSO (v/v/v) was applied for a 60 min gradient elution: 0-1.5 min 740 
at 60% B, 35-45 min at 96% B, 45.1-60 min at 60% B. The Nanospray Flex Ion Source 741 
(ThermoFisher Scientific) provided with a stainless steel emitter was used to generate 742 
positively charged ions at 2.2 kV spray voltage. Precursor ions were measured in full scan 743 
mode within a mass range of m/z 300-1600 at a resolution of 70k FWHM using a maximum 744 
injection time of 120 ms and an automatic gain control target of 1e6. For data-dependent 745 
acquisition, up to 10 most abundant precursor ions per scan cycle with an assigned charge state 746 
of z = 2-6 were selected in the quadrupole for further fragmentation using an isolation width 747 
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of m/z 2.0. Fragment ions were generated in the HCD cell at a normalised collision energy of 748 
30 V using nitrogen gas. Dynamic exclusion of precursor ions was set to 20 s. Fragment ions 749 
were monitored at a resolution of 17.5k (FWHM) using a maximum injection time of 120 ms 750 
and an AGC target of 2e5. 751 
 752 
Protein database search 753 
Thermo raw files were processed by the Proteome Discoverer (PD) software v1.4.0.288 754 
(Thermo). Tandem mass spectra were searched against the Candida Genome Database 755 
(http://www.candidagenome.org/download/sequence/C_albicans_SC5314/Assembly22/curre756 
nt/C_albicans_SC5314_A22_current_orf_trans_all.fasta.gz; status: 2015/05/03) using the 757 
Sequest HT search algorithm. Mass spectra were searched for both unspecific cleavages (no 758 
enzyme) and tryptic peptides with up to 4 missed cleavages. The precursor mass tolerance was 759 
set to 10 ppm and the fragment mass tolerance to 0.02 Da. Target Decoy PSM Validator node 760 
and a reverse decoy database was used for (qvalue) validation of the peptide spectral matches 761 
(PSMs) using a strict target false discovery (FDR) rate of < 1%. Furthermore, we used the 762 
Score versus Charge State function of the Sequest engine to filter out insignificant peptide hits 763 
(xcorr of 2.0 for z=2, 2.25 for z=3, 2.5 for z=4, 2.75 for z=5, 3.0 for z=6). At least two unique 764 
peptides per protein were required for positive protein hits. 765 
 766 
Statistics 767 
TransAM and patch clamp data were analyzed using a paired t-test whilst cytokines, LDH and 768 
calcium influx data were analyzed using ANOVA. Murine in vivo Log(10) cfu/g data was 769 
analyzed using the Mann-Whitney test.  Zebrafish data was analyzed using the Kruskal-Wallis 770 
test with Dunn's multiple comparison correction. In all cases, P < 0.05 was taken to be 771 
significant. 772 
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